This study investigated whether high-dose furosemide improves kidney function in patients with acute renal failure caused by leptospirosis. Six patients received 2 g of furosemide per day, while eight patients with similar conditions were observed without treatment. While furosemide increased urine output, there was no improvement in kidney function or clinical outcomes. Both groups had the same duration of renal failure. The findings suggest that diuresis alone does not lead to functional recovery in this condition.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Acute renal failure remains a significant clinical challenge, particularly in infectious contexts like leptospirosis. Prior research has shown that diuretics are often used to manage fluid overload and promote urine output. However, the impact of high-dose furosemide on renal recovery remains unclear. No prior work had resolved whether diuresis correlates with functional recovery in this setting. That uncertainty drove the need for controlled studies. Established knowledge includes furosemide’s role in promoting diuresis, but its effect on long-term renal function is less certain. This gap motivated researchers to investigate whether enhanced urine output translates to improved renal outcomes. The study aimed to clarify the relationship between diuresis and functional recovery in acute renal failure. Understanding this could refine treatment strategies in patients with severe kidney impairment.
Purpose Of The Study:
The study aimed to evaluate whether high-dose intravenous furosemide improves renal recovery in patients with acute renal failure caused by leptospirosis. Researchers focused on comparing urine output and renal function changes between treated and untreated groups. The motivation stemmed from the need to determine if diuresis alone is sufficient for functional improvement. No prior work had resolved this specific question in leptospirosis-related renal failure. The goal was to assess whether increased urine flow correlates with better clinical outcomes. The study also aimed to compare the duration of renal failure between groups. Researchers sought to determine if diuresis influences disease progression or recovery. This would help clarify the role of diuretics in acute kidney injury management.
The study found that high-dose furosemide promotes diuresis but does not improve renal function or clinical outcomes.
Renal function was assessed using serum creatinine levels and creatinine clearance calculations.
A control group was used to compare the effects of furosemide on diuresis and renal function in patients with similar disease severity.
The duration of renal failure was the same in both the furosemide-treated and control groups.
Main Methods:
Six patients with acute renal failure due to leptospirosis received high-dose intravenous furosemide (2 g/24 hr). A control group of eight patients with similar disease severity and renal impairment was observed without furosemide. Urine flow was measured to assess diuretic response. Serum creatinine levels were monitored to evaluate renal function. Creatinine clearance was calculated to estimate kidney function. The clinical course of each patient was tracked for changes in symptoms and recovery. Duration of renal failure was recorded for both groups. The study used a comparative design to evaluate the effects of furosemide on renal outcomes.
Main Results:
High-dose furosemide induced excellent diuresis in treated patients. Urine output increased significantly compared to the control group. Serum creatinine levels remained unchanged in both groups. Creatinine clearance showed no improvement in either group. The clinical course of the disease was similar between groups. Duration of renal failure was identical in both groups. No significant differences in renal function were observed. The study found no evidence that diuresis improved functional recovery.
Conclusions:
The authors concluded that high-dose furosemide promotes diuresis in acute renal failure due to leptospirosis. However, this diuresis does not improve renal function or clinical outcomes. The study found no evidence that increased urine output correlates with functional recovery. Duration of renal failure remained unchanged in both groups. The authors suggest that diuresis alone may not be sufficient for renal recovery. No prior work had resolved this specific question in leptospirosis-related renal failure. The findings indicate that diuretic use should not be assumed to improve renal function. These results may inform treatment strategies in acute kidney injury management.
No correlation was found between increased urine output and improved clinical outcomes or renal function recovery.
The findings suggest that diuresis alone may not be sufficient for renal recovery and should not be assumed to improve outcomes.